Freeline Therapeutics Holdings PLC reports results for the quarter ended in June - Earnings Summary

Freeline Therapeutics Holdings

16/08/2021 13:25

* Freeline Therapeutics Holdings PLC  FRLN.OQ  reported a
quarterly adjusted loss of $1.12​​ per share for the quarter
ended in June. The mean expectation of six analysts for the
quarter was for a loss of 97 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Freeline Therapeutics Holdings PLC's reported EPS for the
quarter was a loss of $1.12​.
* The mean earnings estimate of analysts had fallen by
about 15.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Freeline Therapeutics Holdings PLC shares had fallen by 59.3%
this quarter and lost 81.8% so far this year.
* The company reported a quarterly loss of $39.87 million.
* Wall Street's median 12-month price target for Freeline
Therapeutics Holdings PLC is $26.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 12:25 p.m.  ​All
figures in US dollars unless otherwise stated